How Cannabidiol Modulates Glutamate in Psychosis Risk
A single dose of cannabidiol glutamate modulation psychosis effects was studied in people at clinical high risk for psychosis. CBD reduced abnormal hippocampal glutamate connections and irregular brain activity during memory tasks. This suggests…
Cannabis Dosing and Tolerability in AIMSS Treatment
This study evaluates aromatase inhibitor joint pain relief using topical cannabis balms in women with AIMSS. The balms were well tolerated and showed promising results. Further research is needed to confirm efficacy and safety.
Cannabinoid Pain Relief: Clinical Evidence Review
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, which represents a specific mechanism for pain relief. This action occurs at ion channels that are critical for transmitting pain…
Endocannabinoid System and Prenatal Cannabis: Clinical Research
Prenatal cannabis neurodevelopment risks include modestly increased chances of autism spectrum disorder and ADHD in offspring. Cannabis crosses the placenta and interacts with the endocannabinoid system during fetal brain development. Clinical research…
Exploring the Internalising Pathway of Cannabis Use in Teens
The internalising pathway cannabis use teens highlights how anxiety symptoms increase the risk of cannabis initiation and escalation. Adolescents with generalised anxiety are particularly vulnerable. Early intervention targeting these symptoms may reduce…
Endocannabinoid System in First-Episode Psychosis Care
People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher risk for legal…
Endocannabinoid System in Trauma: Clinical Research Evidence
Clinical research highlights the role of the endocannabinoid system trauma substance use connection in posttraumatic outcomes. Insomnia symptoms before trauma predict higher rates of alcohol and cannabis use. Understanding this link aids early…
Cannabidiol Cortical Excitability Clinical Trial
This cannabidiol cortical excitability clinical trial data shows CBD did not directly reduce brain electrical excitability at doses up to 700 mg in healthy adults. The findings suggest seizure-control benefits likely arise from interactions with other…
Daily Cannabis Use and Anxiety Relief: Outcomes by Product Type
Daily cannabis anxiety relief outcomes vary significantly by product type and cannabinoid composition. Research shows that flower and edible cannabis products produce different anxiety symptom changes over time. Understanding these outcomes helps guide…
Clinical Research on Endocannabinoid System and PTSD Treatment
Endocannabinoid system PTSD cannabis research reveals trauma-focused treatments remain effective for patients using cannabis. Clinical data shows no significant impairment in therapy outcomes due to cannabis use. These findings support standard…
